Cefotaxime

From WikiMD's WELLNESSPEDIA

Cefotaxime


Cefotaxime is a third-generation Cephalosporin antibiotic. It was first patented in 1976 and came into medical use in 1980. Cefotaxime is used to treat a variety of bacterial infections, including those caused by Streptococcus pneumoniae, Escherichia coli, Haemophilus influenzae, Neisseria gonorrhoeae, and others.

Chemistry[edit]

Cefotaxime is a semi-synthetic, beta-lactam antibiotic, which is resistant to most beta-lactamases. It is derived from Cephalosporin C, a naturally occurring antibiotic produced by the fungus Acremonium. Cefotaxime works by inhibiting the synthesis of the bacterial cell wall, leading to cell death.

Pharmacology[edit]

Cefotaxime is administered either by intravenous or intramuscular injection. It is metabolized in the body and excreted in the urine. The half-life of cefotaxime is approximately one hour in adults.

Clinical Use[edit]

Cefotaxime is used to treat a wide range of infections, including pneumonia, meningitis, gonorrhea, and infections of the skin, urinary tract, and abdomen. It is also used for surgical prophylaxis in patients undergoing abdominal or pelvic surgery.

Side Effects[edit]

Common side effects of cefotaxime include rash, diarrhea, and changes in white blood cell count. Serious side effects may include Clostridium difficile infection, allergic reactions, and seizures.

Resistance[edit]

Resistance to cefotaxime and other cephalosporins can occur through several mechanisms, including the production of beta-lactamase enzymes, alteration of penicillin-binding proteins, and efflux pumps.

See Also[edit]

Types of antibacterials




Oral Cephalosporins

Parenteral Cephalosporins

This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.